Birdwatch Archive - Rating Details

Birdwatch Note Rating

2023-08-25 21:55:18 UTC - NOT_HELPFUL

Rated by Participant: 3C0496A8E6CB85C4321A4B8C7C872051245EEFE30065148FE1767AE741CBE834
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

noteId - 1695190002055970932
participantId -
raterParticipantId - 3C0496A8E6CB85C4321A4B8C7C872051245EEFE30065148FE1767AE741CBE834
createdAtMillis - 1693000518176
version - 2
agree - 0
disagree - 0
helpful - 0
notHelpful - 0
helpfulnessLevel - NOT_HELPFUL
helpfulOther - 0
helpfulInformative - 0
helpfulClear - 0
helpfulEmpathetic - 0
helpfulGoodSources - 0
helpfulUniqueContext - 0
helpfulAddressesClaim - 0
helpfulImportantContext - 0
helpfulUnbiasedLanguage - 0
notHelpfulOther - 0
notHelpfulIncorrect - 1
notHelpfulSourcesMissingOrUnreliable - 1
notHelpfulOpinionSpeculationOrBias - 0
notHelpfulMissingKeyPoints - 0
notHelpfulOutdated - 0
notHelpfulHardToUnderstand - 0
notHelpfulArgumentativeOrBiased - 0
notHelpfulOffTopic - 0
notHelpfulSpamHarassmentOrAbuse - 0
notHelpfulIrrelevantSources - 0
notHelpfulOpinionSpeculation - 1
notHelpfulNoteNotNeeded - 0
ratingsId - 16951900020559709323C0496A8E6CB85C4321A4B8C7C872051245EEFE30065148FE1767AE741CBE834